Lopinavir/Ritonavir (LPV/r) Oral Solution 80+20mg/ml is a pioneering therapeutic solution specifically designed to combat HIV-1 in adults and children above the age of 2. This solution belongs to the distinguished class of Protease Inhibitors (PI), making it an effective defense against HIV-1. The package contains 5 bottles, each with a volume of 60ml, and each milliliter is imbued with a strong concentration of 80mg Lopinavir and 20mg Ritonavir.
Lopinavir/Ritonavir is recognized for its boosted protease inhibitor function, a feature that puts it at the forefront of HIV management. The protease inhibitors operate by restraining the viral protease, a crucial enzyme needed by HIV-1 for replication. The drug's oral administration route promotes easy, non-invasive application and widespread inhibition of HIV-1 propagation.
The Lopinavir/Ritonavir (LPV/r) Oral Solution 80+20mg/ml has demonstrated considerable effectiveness against HIV-1 as evident by its prequalification from the World Health Organization (WHO). This potent and reliable solution embodies our commitment to providing the highest level of patient care.